Clinical Trials in Taegu, South Korea
6 recruiting
Showing 1–7 of 7 trials
Recruiting
Phase 3
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Breast NeoplasmsTriple Negative Breast NeoplasmsHR Low-Positive/HER2-Negative Breast Neoplasms
Merck Sharp & Dohme LLC2,400 enrolled283 locationsNCT06966700
Recruiting
Phase 3
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
Primary IgA Nephropathy
Novartis Pharmaceuticals540 enrolled161 locationsNCT04557462
Recruiting
Asciminib RMP Study
Chronic Myeloid Leukemia
Novartis Pharmaceuticals600 enrolled17 locationsNCT05943522
Recruiting
Leqvio rPMS (Regulatory Post-Marketing Surveillance in Korea)
Primary Hypercholesterolemia or Mixed Dyslipidemia
Novartis Pharmaceuticals1,500 enrolled4 locationsNCT06770543
Recruiting
A 24-week Prospective, Open-label, Multicenter, Single-arm rPMS Study in Real-world Setting for Atectura®
Asthma
Novartis Pharmaceuticals600 enrolled18 locationsNCT05217810
Recruiting
A PMS of Jakavi® in Patients With Steroid-Refractory Graft-versus-Host Disease (SR-GvHD) in Korea
Graft-Versus-Host Disease
Novartis Pharmaceuticals127 enrolled11 locationsNCT05621733
Recruiting
Regulatory Post-Marketing Surveillance Study for Brolucizumab
Neovascular Age-related Macular Degeneration
Novartis Pharmaceuticals3,000 enrolled28 locationsNCT04985487